Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 74 matching records.
74 results — page 1 of 4
- Level DLaboratory StudyEurope PMC
Comparing the growth kinetics and characteristics of Wharton's jelly derived mesenchymal stem cells expanded using different culture mediums
Laboratory Study on Immune Modulation, published in Cytotechnology (2025) — summary generated from the PubMed abstract.
- 2025
Cytotechnology2 citations - Level BClinical TrialEurope PMC
Consecutive intrabronchial administration of Wharton's jelly-derived mesenchymal stromal cells in ECMO-supported pediatric patients with end-stage interstitial lung disease: a safety and feasibility study (CIBA method)
Clinical Trial on Face & Skin, Systemic / IV, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
- 2025
Stem Cell Res Ther3 citations - Level DLaboratory StudyEurope PMC
Evaluation of the Interaction Between Wharton's Jelly-Derived Mesenchymal Stem Cells and β-Mercaptoethanol
Laboratory Study on Spinal Cord Injury, Neuroinflammation, published in Cureus (2025) — summary generated from the PubMed abstract.
- 2025
Cureus2 citations - Level BClinical TrialEurope PMC
The transforming role of wharton's jelly mesenchymal stem cell-derived exosomes for diabetic foot ulcer healing: a randomized controlled clinical trial
Clinical Trial with a reported sample of 53 on Diabetic Foot, Chronic Wound, Chronic Inflammation, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
- 2025
- n = 53
Stem Cell Res Ther5 citations - Level DAnimal StudyPubMed
Selective Paracrine Modulation of Stromal Cells: Wharton's Jelly MSC Secretome Enhances Adipose-Derived MSC Functionality While Maintaining Dermal Fibroblast Quiescence.
Animal Study on Chronic Wound, published in Int J Mol Sci (2025) — summary generated from the PubMed abstract.
- 2025
Int J Mol Sci - Level DLaboratory StudyPubMed
Therapeutic Potential and Comparison of the Effects of Mummy on Mesenchymal Stem Cells Derived from Wharton's Jelly and Adipose Tissue Cultured with Human Fibroblasts.
Laboratory Study on Chronic Wound, Scar, published in Int J Hematol Oncol Stem Cell Res (2025) — summary generated from the PubMed abstract.
- 2025
Int J Hematol Oncol Stem Cell Res - Level DLaboratory StudyPubMed
Enhancing insulin sensitivity in type 2 diabetes mellitus using apelin-loaded small extracellular vesicles from Wharton's jelly-derived mesenchymal stem cells: a novel therapeutic approach.
Laboratory Study on Type 2 Diabetes, Chronic Inflammation, published in Diabetol Metab Syndr (2024) — summary generated from the PubMed abstract.
- 2024
Diabetol Metab Syndr - Level CProspective StudyPubMed
Exosomes Secreted by Wharton's Jelly-Derived Mesenchymal Stem Cells Promote the Ability of Cell Proliferation and Migration for Keratinocyte.
Prospective Study on Chronic Wound, Immune Modulation, published in Int J Mol Sci (2024) — summary generated from the PubMed abstract.
- 2024
Int J Mol Sci - Level DAnimal StudyPubMed
Reversal of Pulmonary Fibrosis: Human Umbilical Mesenchymal Stem Cells from Wharton's Jelly versus Human-Adipose-Derived Mesenchymal Stem Cells.
Animal Study, published in Int J Mol Sci (2023) — summary generated from the PubMed abstract.
- 2023
Int J Mol Sci11 citations - Level DLaboratory StudyPubMed
Apoptosis Related Human Wharton's Jelly-Derived Stem Cells Differentiation into Osteoblasts, Chondrocytes, Adipocytes and Neural-like Cells-Complete Transcriptomic Assays.
Laboratory Study on Face & Skin, published in Int J Mol Sci (2023) — summary generated from the PubMed abstract.
- 2023
Int J Mol Sci - Level DLaboratory StudyPubMed
Expression Profile of New Marker Genes Involved in Differentiation of Human Wharton's Jelly-Derived Mesenchymal Stem Cells into Chondrocytes, Osteoblasts, Adipocytes and Neural-like Cells.
Laboratory Study on Immune Modulation, published in Int J Mol Sci (2023) — summary generated from the PubMed abstract.
- 2023
Int J Mol Sci - Level DLaboratory StudyPubMed
Comparative Analysis of Porcine Adipose- and Wharton's Jelly-Derived Mesenchymal Stem Cells.
Laboratory Study, published in Animals (Basel) (2023) — summary generated from the PubMed abstract.
- 2023
Animals (Basel)7 citations - Level BClinical TrialEurope PMC
Feline Wharton's jelly-derived mesenchymal stem cells as a feeder layer for oocytes maturation and embryos culture in vitro
Clinical Trial, published in Front Vet Sci (2023) — summary generated from the PubMed abstract.
- 2023
Front Vet Sci1 citations - Level DAnimal StudyEurope PMC
Human Wharton's jelly-derived mesenchymal stromal cells promote bone formation in immunodeficient mice when administered into a bone microenvironment
Animal Study on Systemic / IV, published in J Transl Med (2023) — summary generated from the PubMed abstract.
- 2023
J Transl Med5 citations - Level BClinical TrialEurope PMC
Application of Wharton jelly-derived mesenchymal stem cells in patients with pulmonary fibrosis
Clinical Trial on Face & Skin, published in Stem Cell Res Ther (2022) — summary generated from the PubMed abstract.
- 2022
Stem Cell Res Ther22 citations - Level BClinical TrialEurope PMC
Suitability of Human Mesenchymal Stem Cells Derived from Fetal Umbilical Cord (Wharton's Jelly) as an Alternative In Vitro Model for Acute Drug Toxicity Screening
Clinical Trial, published in Cells (2022) — summary generated from the PubMed abstract.
- 2022
Cells12 citations - Level DLaboratory StudyPubMed
Comparison Study on the Effect of Mesenchymal Stem Cells-Conditioned Medium Derived from Adipose and Wharton's Jelly on Versican Gene Expression in Hypoxia.
Laboratory Study on Face & Skin, published in Iran Biomed J (2022) — summary generated from the PubMed abstract.
- 2022
Iran Biomed J - Level CProspective StudyPubMed
Shipping Temperature, Time and Media Effects on Equine Wharton's Jelly and Adipose Tissue Derived Mesenchymal Stromal Cells Characteristics.
Prospective Study on Hip, published in Animals (Basel) (2022) — summary generated from the PubMed abstract.
- 2022
Animals (Basel) - Level BClinical TrialEurope PMC
Human Wharton's Jelly-derived mesenchymal stem cells prevent acetaminophen-induced liver injury in a mouse model unlike human dermal fibroblasts
Clinical Trial, published in Arch Toxicol (2022) — summary generated from the PubMed abstract.
- 2022
Arch Toxicol14 citations - Level DLaboratory StudyEurope PMC
3D in-vitro cultures of human bone marrow and Wharton's jelly derived mesenchymal stromal cells show high chondrogenic potential
Laboratory Study on Cartilage Damage, published in Front Bioeng Biotechnol (2022) — summary generated from the PubMed abstract.
- 2022
Front Bioeng Biotechnol18 citations - Level DLaboratory StudyEurope PMC
Improvement of Corneal Nerve Regeneration in Diabetic Rats Using Wharton's Jelly-Derived Mesenchymal Stem Cells and their Conditioned Medium
Laboratory Study with a reported sample of 7, published in Int J Mol Cell Med (2022) — summary generated from the PubMed abstract.
- 2022
- n = 7
Int J Mol Cell Med1 citations - Level DAnimal StudyEurope PMC
Mesenchymal Stem Cells Derived from Wharton's Jelly Can Differentiate into Schwann Cell-Like Cells and Promote Peripheral Nerve Regeneration in Acellular Nerve Grafts
Animal Study, published in Tissue Eng Regen Med (2021) — summary generated from the PubMed abstract.
- 2021
Tissue Eng Regen Med27 citations - Level AMeta-analysisEurope PMC
Wharton's Jelly Mesenchymal Stem Cell-Derived Extracellular Vesicles Reduce SARS-CoV2-Induced Inflammatory Cytokines Under High Glucose and Uremic Toxin Conditions
Meta-analysis with a reported sample of 19 on Chronic Inflammation, Immune Modulation, published in Stem Cells Dev (2021) — summary generated from the PubMed abstract.
- 2021
- n = 19
Stem Cells Dev22 citations - Level DLaboratory StudyEurope PMC
A Two-Stage Process for Differentiation of Wharton's Jelly-Derived Mesenchymal Stem Cells into Neuronal-like Cells
Laboratory Study on Neuroinflammation, published in Stem Cells Int (2021) — summary generated from the PubMed abstract.
- 2021
Stem Cells Int4 citations
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406